Chinese Severe Brain Injury Trial
Not yet recruiting
- Conditions
- Severe Brain Injury
- Registration Number
- NCT06179836
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Brief Summary
Building a Large Chinese Cohort(Chinese Severe brain injury Trial)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
- a clear cause of brain injury
- disorders of consciousness, GCS≤12
- within six months of onset
Exclusion Criteria
- not applicable
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glasgow Outcome Scale 6 months after severe Brain Injury The unabbreviated scale title is Glasgow Outcome Scale. GOS includes a score of 1-5, with the higher the score, the better the prognosis.
- Secondary Outcome Measures
Name Time Method Glasgow Outcome Scale 3 months and 12 months after severe Brain Injury The unabbreviated scale title is Glasgow Outcome Scale. GOS includes a score of 1-5, with the higher the score, the better the prognosis.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie recovery in severe traumatic brain injury patients enrolled in NCT06179836?
How do observational outcomes from NCT06179836 compare to standard-of-care treatments for diffuse axonal injury in China?
What biomarkers are being evaluated for prognosis prediction in the Chinese Severe Brain Injury Trial cohort?
What adverse event profiles are associated with current neuroprotective strategies in severe brain injury studies?
How might findings from NCT06179836 influence combination therapies targeting neuroinflammation and glial scar formation?